Date published: 2026-4-26

1-800-457-3801

SCBT Portrait Logo
Seach Input

IFN-α2 Inhibitors

IFN-α2 inhibitors constitute a distinct class of chemical compounds characterized by their ability to selectively target and modulate the activity of interferon-alpha 2 (IFN-α2), a type of cytokine integral to the intricate network of immune system regulation. These inhibitors are designed to interact with specific molecular components involved in the IFN-α2 signaling cascade, thereby exerting regulatory influence over the cellular responses triggered by this cytokine. Structurally, IFN-α2 inhibitors can encompass a variety of chemical scaffolds and functional groups, enabling them to bind to key protein targets, receptors, or downstream elements within the IFN-α2 pathway. Through these interactions, IFN-α2 inhibitors interfere with the transmission of intracellular signals that initiate and sustain the immune response.

By selectively attenuating IFN-α2-related signaling events, these compounds offer the potential to modulate immune cell activities and molecular processes linked to immune function, without affecting other cytokine signaling pathways. As research progresses, a deeper understanding of the chemical mechanisms underpinning IFN-α2 inhibitors may unlock novel avenues for manipulating immune responses and elucidate broader implications for the field of immune system regulation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Ruxolitinib

941678-49-5sc-364729
sc-364729A
sc-364729A-CW
5 mg
25 mg
25 mg
$251.00
$500.00
$547.00
16
(1)

Although primarily known as a Janus kinase (JAK) inhibitor, ruxolitinib can indirectly influence the activity of IFN-α2 by affecting JAK-STAT signaling pathways involved in cytokine signaling.

Baricitinib

1187594-09-7sc-364730
sc-364730A
5 mg
25 mg
$200.00
$664.00
(1)

Similar to ruxolitinib, baricitinib is a JAK inhibitor with potential effects on interferon signaling pathways.

hydroxychloroquine

118-42-3sc-507426
5 g
$57.00
1
(0)

While primarily used for malaria and certain autoimmune conditions like lupus and rheumatoid arthritis, hydroxychloroquine has been explored for its potential to inhibit interferon-alpha production.

Apremilast

608141-41-9sc-480062
5 mg
$444.00
(0)

Apremilast is a phosphodiesterase 4 (PDE4) inhibitor that could potentially modulate immune responses and cytokine production, including interferon-alpha.

Filgotinib

1206161-97-8sc-507393
10 mg
$150.00
(0)

Filgotinib is a JAK1 inhibitor that could impact interferon-alpha signaling as part of its broader effects on cytokine pathways.